Table 2.
The top 10 productive journals in lung cancer immunotherapy from 2010 to 2022.
| Journals | Paper number | Total citation | Citation per paper | Citation per paper per year a | H-index | G-index | IF (2021) |
|---|---|---|---|---|---|---|---|
| Lung Cancer | 150 | 4543 | 30.29 | 9.07 | 36 | 60 | 6.081 |
| Thorac. Cancer | 138 | 652 | 4.72 | 2.84 | 14 | 4 | 3.223 |
| Clin. Lung Cancer | 97 | 1427 | 14.71 | 5.49 | 19 | 34 | 4.840 |
| Front. Oncol. | 90 | 312 | 3.47 | 2.63 | 9 | 12 | 5.738 |
| Cancer Immunol. Immunother. | 80 | 1654 | 20.68 | 8.47 | 22 | 39 | 6.630 |
| J. Immunother. Cancer | 74 | 1575 | 21.28 | 8.61 | 22 | 37 | 12.469 |
| Transl. Lung Cancer Res. | 68 | 296 | 4.35 | 2.79 | 9 | 14 | 4.726 |
| Cancers | 61 | 417 | 6.84 | 4.23 | 13 | 18 | 6.575 |
| J. Thorac. Oncol. | 60 | 4768 | 79.47 | 18.80 | 40 | 60 | 20.121 |
| OncoImmunology | 49 | 1293 | 26.39 | 6.69 | 19 | 35 | 7.723 |
a
Papers published in 2022 were not included for calculating citation per paper per year.